The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...
Pfizer agreed to a $44 million Chantix settlement. Here's who may qualify, how to file a claim and the deadline to submit.
Pfizer Inc. (NYSE:PFE) is beginning to show signs of steadier growth following the sharp decline in its pandemic-related ...
Pfizer shares sit near a 52-week high after years of post-pandemic punishment, and now Wall Street analysts are quietly ...
Most investors look at the dividend payout ratio when they consider dividend safety. This metric compares dividends to ...
COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...
The new shots, available soon, are designed to protect against the dominant strain and will be covered by insurance.
Pfizer is facing material patent expirations over the next two years, but that will be over by 2030.
Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the ...
Stocks that don't generate strong returns can still make good dividend investments. As long as their payouts are sustainable and the businesses are in solid shape, they can be appealing options for ...
A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with a new owner and a 21-year lease to an unnamed global biopharmaceutical ...
Pfizer, Chevron, and AbbVie have already rewarded dividend investors with strong 2026 gains, but the bull case for 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results